A novel therapeutic modality using CRISPR-engineered dendritic cells to treat allergies
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Byoungjae | - |
dc.contributor.author | Lee, Young Eun | - |
dc.contributor.author | Yeon, Ji Woo | - |
dc.contributor.author | Go, Ga-Yeon | - |
dc.contributor.author | Byun, Junhyoung | - |
dc.contributor.author | Lee, Kijeong | - |
dc.contributor.author | Lee, Hyomin K. | - |
dc.contributor.author | Hur, Junho K. | - |
dc.contributor.author | Jang, Mihue | - |
dc.contributor.author | Kim, Tae Hoon | - |
dc.date.accessioned | 2022-03-01T07:42:24Z | - |
dc.date.available | 2022-03-01T07:42:24Z | - |
dc.date.created | 2021-12-07 | - |
dc.date.issued | 2021-06 | - |
dc.identifier.issn | 0142-9612 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/137351 | - |
dc.description.abstract | Despite the important roles of dendritic cells (DCs) in airway allergies, current therapeutic strategies such as drugs, allergen immunotherapy and biologics haven't been targeted at them. In this study, we established a promising DC-based therapeutic approach for the alleviation of allergic rhinitis (AR)-associated allergic reactions, using clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9-mediated targeted gene disruption. RNA sequencing analysis revealed upregulation of vacuolar protein sorting 37 B (VPS37B) in ARderived DCs, indicating a novel molecular target. Following antigen presentation, VPS37A and VPS37B enabled endocytosis of the mannose receptor, which recognizes the house dust mite (HDM) allergen Der p 1. DCs with targeted disruption of VPS37A/B alleviated Th2 cytokine production when co-cultured in vitro with allogeneic naive CD4+ T cell from patients with AR. Furthermore, nasal administration of Vps37a/b-disrupted bone marrow DCs to a mouse model of AR resulted in strongly reduced AR-related symptoms. Thus, this novel modality using genetically engineered DCs can provide an effective therapeutic and preventative strategy for allergic diseases. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | ELSEVIER SCI LTD | - |
dc.subject | DC-SIGN | - |
dc.subject | RECEPTOR | - |
dc.subject | ESCRT | - |
dc.subject | DIFFERENTIATION | - |
dc.subject | IMMUNOTHERAPY | - |
dc.subject | POLARIZATION | - |
dc.subject | RECOGNITION | - |
dc.subject | ACTIVATION | - |
dc.subject | ADHESION | - |
dc.subject | GUIDES | - |
dc.title | A novel therapeutic modality using CRISPR-engineered dendritic cells to treat allergies | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Tae Hoon | - |
dc.identifier.doi | 10.1016/j.biomaterials.2021.120798 | - |
dc.identifier.scopusid | 2-s2.0-85104761282 | - |
dc.identifier.wosid | 000649667700002 | - |
dc.identifier.bibliographicCitation | BIOMATERIALS, v.273 | - |
dc.relation.isPartOf | BIOMATERIALS | - |
dc.citation.title | BIOMATERIALS | - |
dc.citation.volume | 273 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Engineering | - |
dc.relation.journalResearchArea | Materials Science | - |
dc.relation.journalWebOfScienceCategory | Engineering, Biomedical | - |
dc.relation.journalWebOfScienceCategory | Materials Science, Biomaterials | - |
dc.subject.keywordPlus | ACTIVATION | - |
dc.subject.keywordPlus | ADHESION | - |
dc.subject.keywordPlus | DC-SIGN | - |
dc.subject.keywordPlus | DIFFERENTIATION | - |
dc.subject.keywordPlus | ESCRT | - |
dc.subject.keywordPlus | GUIDES | - |
dc.subject.keywordPlus | IMMUNOTHERAPY | - |
dc.subject.keywordPlus | POLARIZATION | - |
dc.subject.keywordPlus | RECEPTOR | - |
dc.subject.keywordPlus | RECOGNITION | - |
dc.subject.keywordAuthor | Adoptive cell therapies | - |
dc.subject.keywordAuthor | Allergies | - |
dc.subject.keywordAuthor | CRISPR | - |
dc.subject.keywordAuthor | Dendritic cells | - |
dc.subject.keywordAuthor | Vacuolar protein sorting 37 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.